-
Signature
-
/s/ Brian E. Anderson, attorney-in-fact for Hiran Bhadra
-
Issuer symbol
-
BDC
-
Transactions as of
-
04 Dec 2025
-
Transactions value $
-
-$317,845
-
Form type
-
4
-
Filing time
-
08 Dec 2025, 16:25:41 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Bhadra Hiran |
SVP, Strategy & Technology |
C/O BELDEN INC., 1 N. BRENTWOOD BLVD., 15TH FLOOR, SAINT LOUIS |
/s/ Brian E. Anderson, attorney-in-fact for Hiran Bhadra |
08 Dec 2025 |
0002014699 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BDC |
Common Stock Holding |
Options Exercise |
$266K |
+4.85K |
+18.56% |
$54.89 |
31K |
04 Dec 2025 |
Direct |
F1 |
| transaction |
BDC |
Common Stock Holding |
Disposed to Issuer |
-$392K |
-3.25K |
-10.49% |
$120.70 |
27.7K |
04 Dec 2025 |
Direct |
F2 |
| transaction |
BDC |
Common Stock Holding |
Sale |
-$192K |
-1.6K |
-5.77% |
$120.00 |
26.1K |
05 Dec 2025 |
Direct |
F3 |
| holding |
BDC |
Common Stock Holding |
|
|
|
|
|
718 |
04 Dec 2025 |
By 401(k) Plan |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BDC |
Stock Appreciation Rights |
Options Exercise |
$0 |
-4.85K |
-100% |
$0.00 |
0 |
04 Dec 2025 |
Common Stock |
4.85K |
$54.89 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: